SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION
The prescribed route of administration for each Systemic Anti-Cancer Therapy Drug Administration in a Systemic Anti-Cancer Therapy Drug Cycle.
Format / Length
an2
Description
Permitted Codes
| Code | Description | 
|---|---|
| 01 | Intravenous | 
| 02 | Oral | 
| 03 | Intrathecal | 
| 04 | Intramuscular | 
| 05 | Subcutaneous | 
| 06 | Intraarterial | 
| 07 | Intraperitoneal | 
| 08 | Other intracavity Intracavernous | 
| 09 | Intravesical (Intra-Vesicular) | 
| 10 | Intratumour / Intralesional (Retired 1 September 2019 ) | 
| 11 | Cutaneous (Topical) | 
| 12 | Intradermal | 
| 13 | Intratumour | 
| 14 | Intralesional | 
| 99 | Other (Retired 1 September 2019 ) | 
| 98 | Other (not listed) | 
Also Known As
This data element is also known by these names:
| Context | Alias | 
|---|---|
| Plural | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTES OF ADMINISTRATION | 
Where Used
| Type | Link | How used | 
|---|---|---|
| Data Set | Systemic Anti-Cancer Therapy Data Set | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION | 
| Data Element | SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION | references in description SYSTEMIC ANTI-CANCER THERAPY DRUG ROUTE OF ADMINISTRATION |